Published in Cancer Weekly, October 19th, 2004
"However, the use of formalin-fixed, paraffin-embedded specimens for quantitative real-time polymerase chain reaction (PCR) is not yet a standard diagnostic method in many laboratories, in particular for the quantification of human papillomavirus (HPV). Particularly high-risk HPV types are involved in almost 100% of the carcinogenesis of cervical cancer," wrote K. Biedermann and colleagues.
They "compared the diagnostic applicability and sensitivity of real-time PCR to that of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.